Delivery Order SPE2DB24D2100-SPE2DB25FBECJ
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,060,938 units of the prescription medication Vyvanse 60 mg capsules. The contract has a firm fixed price of $1,143.32 and a period of performance through April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,802.45, is for the delivery of 4,568,101,166 units of the prescription medication Vyvanse 40 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 2, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the medication Vyvanse 50 mg capsules. The contract has a firm fixed-price of $3,604.44 and a performance period through May 7, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 100 units of the medication Vyvanse 30 mg capsules, with a firm fixed price of $1,849.04 and a performance period ending on April 21, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,308.91 firm fixed-price contract is for the delivery of 4,567,644,043 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of March 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,162.05, is for the supply of Vyvanse 60 mg capsules. It is a firm-fixed-price contract with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,322.46, is for the delivery of Vyvanse 60 mg capsules. It is a firm fixed-price contract with an ultimate completion date of April 9, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,162.15, is for the provision of 4,566,357,932 units of the prescription medication Vyvanse 60 mg capsule. The contract is a firm-fixed-price delivery order with a completion date of November 7, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the prescription medication Vyvanse 30 mg capsules. The contract has a ceiling value of $1,735.74 and a period of performance through May 20, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,128.81, is for the delivery of 100 capsules of the medication Vyvanse 60 mg. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...